IL10 and non-small cell lung carcinoma: Notably, the elevation of IL-6, IL-8, and IL-10 observed in patients paralleled that seen in the H292 xenograft model, suggesting these cytokines may represent conserved signatures of NSCLC-associated systemic inflammation.